Key points
- BLSM (BlossomHill Therapeutics) leads with a Very Strong Insider Score distinct insiders deployed $25.2M in aggregate buying.
- Healthcare dominates the daily leaderboard: six of the top eight stocks are healthcare or pharma names, signaling coordinated insider confidence in the sector.
- ATTO (Attovia Therapeutics) saw $45.9M in insider purchases across 5 distinct buyers; PNAQ (Pinnacle Acquisition Corp) drew $29.8M from 6 buyers.
Healthcare insiders moved in striking clusters today. BlossomHill Therapeutics (BLSM), a mid-cap biotech player, captured the Very Strong Insider Score band with six distinct insiders collectively buying $25.2 million in stock. That level of coordinated buying—often tied to pre-announcement confidence or sector tailwinds—rarely surfaces outside of catalysts or leadership conviction. The breadth (six separate buyers across likely different share classes or time windows) suggests institutional depth rather than a single whale bet.
But BLSM was not alone. Attovia Therapeutics (ATTO), another biologics-focused name, saw five distinct insiders accumulate $45.9 million—the largest dollar total on today's leaderboard. That pairing, combined with Tiziana Life Sciences (TLSA) rounding out the top spot with a Very Strong score on $1.04M in buying from two distinct insiders, points to a sector-wide conviction play. Healthcare accounts for six of the top eight Insider Score rankings today, a rarity that historically has preceded either sector-wide optimism or company-specific catalysts in the biotech calendar (clinical readouts, regulatory decisions, or M&A whispers).
Large-cap pharma also registered: Pfizer (PFE) attracted $2.96M from three distinct insiders and holds a Strong Insider Score. While the dollar amount is modest relative to its market cap, the presence of multiple insiders buying simultaneously in a mega-cap name—especially after a period of mixed biotech sentiment—may suggest confidence in near-term catalysts or dividend sustainability.
Pinnacle Acquisition Corp (PNAQ) represents the non-healthcare outlier on the top tier: six distinct buyers deployed $29.8M, landing it a Strong Insider Score. SPAC insiders moving in clusters this size typically signal either an imminent deal announcement or pre-filing accumulation tied to internal knowledge. Monitor PNAQ investor filings and news wires closely over the next 48 hours.
The sector tilt is unmistakable: healthcare and biotech insiders are buying with high conviction and broad participation. This pattern may suggest limited downside risk is priced in—or, conversely, that insiders are frontrunning sector rotation as rates stabilize and growth-stage biotech becomes tactical again. Investors may want to monitor whether the cluster extends beyond today's close or reverses as profit-taking materializes.
The Bottom Line
Healthcare insiders are moving in size and in coordination today. Track whether today's cluster extends into tomorrow's session and whether any of these names (particularly BLSM and ATTO) announce material news within Pro hours. Visit our top Insider Scores feed for real-time updates on sector-wide conviction patterns.